Blood-Air Interface during Cardiopulmonary Bypass

The aim of this study was to compare the systemic blood activation with open and closed perfusion management during cardiopulmonary bypass. In 30 patients undergoing coronary artery bypass grafting, we prospectively studied systemic blood activation, blood loss and the need for donor blood. In 15 patients we used an open venous reservoir consisting of a hard shell venous reservoir with an integrated cardiotomy filter. In another 15 patients we used a totally closed venous reservoir consisting of a collapsible venous reservoir, no coronary suction, modified vent and cell saver. Venous blood samples were collected pre, post and 24 hours postoperatively. Sex, age and perfusion times were identical in both groups. There were no statistically significant differences in concentrations of FXIIa and C3a, amount of blood loss and need for donor blood. Interleukin-6 and Elastase levels showed trends toward a lesser inflammatory reaction in closed venous reservoir patients. Modification of perfusion management with optimized air management does not seem to be an effective strategy in reducing the inflammatory response and influencing the coagulation system in this small cohort.

[1]  M. Entman,et al.  Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. , 1999, Circulation.

[2]  J. Schaper,et al.  Reperfusion Injury: Fact or Myth? , 1997, Journal of cardiac surgery.

[3]  A. George,et al.  Blood contact activation: pathophysiological effects and therapeutic approaches , 1996, Perfusion.

[4]  P. Everts,et al.  Systemic blood activation with open and closed venous reservoirs. , 1995, The Annals of thoracic surgery.

[5]  W. van Oeveren,et al.  Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.

[6]  C. Wildevuur,et al.  Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.

[7]  J. Utley Pathophysiology of Cardiopulmonary Bypass: Current Issues , 1990, Journal of cardiac surgery.

[8]  R. Masters,et al.  Pro: the superiority of the membrane oxygenator. , 1989, Journal of cardiothoracic anesthesia.

[9]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.

[10]  F. White A comparative physiological approach to hypothermia. , 1981, The Journal of thoracic and cardiovascular surgery.

[11]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[12]  J. Dunn,et al.  Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.

[13]  K. Taylor,et al.  Haemodynamic effects of angiotensin converting enzyme inhibition after cardiopulmonary bypass in dogs. , 1980, Cardiovascular research.

[14]  J. Grant,et al.  Comparative studies of pulsatile and nonpulsatile flow during cardiopulmonary bypass. II. The effects on adrenal secretion of cortisol. , 1978, The Journal of thoracic and cardiovascular surgery.

[15]  R. Reeves The interaction of body temperature and acid-base balance in ectothermic vertebrates. , 1977, Annual review of physiology.